Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Cox John
Relationship:  
City:   Weston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   44,968    

Indirect Shares

   4,444      
Direct Value   $8,806,473    

Indirect Value

   $0      
Total Shares   49,412      
Total Value   $8,806,473      


Biogen Idec Inc $8,504,391 Repligen Corp $145,982 Dyne Therapeutics, Inc. $156,100 Biogen Idec Inc $8,504,391 Repligen Corp $145,982 Dyne Therapeutics, Inc. $156,100
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    4    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   4.0   
     Percentage Gain/Loss :
     0.0%
 401.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biogen Idec Inc BIIB EVP Pharmaceutical Ope... 2016-04-01 39,045 0    Premium*  
            Repligen Corp RGEN Director 2020-03-24 923 2015-05-21 0    Premium*  
            Bioverativ Inc. BIVV Chief Executive Office... 2018-03-08 0 2017-02-28 0    Premium*  
            Sigilon Therapeutics, Inc. SGTX 2023-08-11 0 2020-12-08 4,444    Premium*  
            Dyne Therapeutics, Inc. DYN 2024-03-25 5,000 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2015-03-25 4 AS $449.06 $5,393,211 D/D (12,010) 25,567 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       –      –    2011-04-13 4 AS $80.00 $2,898,720 D/D (36,234) 10,353 0 -
RGEN Repligen Corp Director   –       •      –    2020-03-18 4 S $95.13 $2,547,035 D/D (26,736) 2,781 0 %
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       –      –    2011-04-13 4 OE $49.31 $2,055,646 D/D 36,234 46,587 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2017-02-28 4 D $43.42 $1,748,144 D/D (37,931) 189,048 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2018-02-22 4 D $104.30 $1,457,384 D/D (13,973) 190,888 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2018-02-14 4 D $103.52 $1,119,983 D/D (10,819) 204,861 0 -
RGEN Repligen Corp Director   –       •      –    2020-03-04 4 S $93.39 $933,900 D/D (10,000) 2,781 0 %
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2015-02-09 4 D $396.88 $877,105 D/D (2,210) 30,534 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2018-02-11 4 D $103.05 $790,600 D/D (7,672) 191,341 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2014-02-09 4 D $315.54 $697,974 D/D (2,212) 22,921 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2015-02-12 4 D $392.11 $690,506 D/D (1,761) 32,511 0 -
RGEN Repligen Corp Director   –       •      –    2020-03-18 4 OE $12.91 $651,603 D/D 26,736 29,517 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2015-02-08 4 D $402.00 $617,874 D/D (1,537) 28,053 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2018-02-23 4 D $104.74 $606,864 D/D (5,794) 185,094 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       –      –    2011-04-11 4 AS $78.00 $538,200 D/D (6,900) 10,353 0 -
BIVV Bioverativ Inc. Chief Executive Officer   •       •      –    2017-03-31 4 D $54.46 $458,335 D/D (8,416) 180,632 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2014-02-08 4 D $315.54 $454,693 D/D (1,441) 20,442 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       –      –    2011-04-21 4 AS $100.00 $435,000 D/D (4,350) 10,353 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       –      –    2010-10-28 4 AS $63.00 $434,700 D/D (6,900) 18,254 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2014-02-23 4 D $347.11 $426,251 D/D (1,228) 25,478 0 -
RGEN Repligen Corp Director   –       •      –    2020-02-24 4 S $92.76 $413,455 D/D (4,455) 2,781 0 %
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2016-02-12 4 D $247.22 $383,685 D/D (1,552) 30,088 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2014-02-12 4 D $323.04 $342,099 D/D (1,059) 24,108 0 -
BIIB Biogen Idec Inc EVP Pharmaceutical Oper & Tech   •       •      –    2015-03-25 4 OE $60.56 $333,571 D/D 5,066 37,577 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us